Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICUCW) Income towards Parent Company (2023 - 2025)

SeaStar Medical Holding's Income towards Parent Company history spans 3 years, with the latest figure at -$2.9 million for Q4 2025.

  • For Q4 2025, Income towards Parent Company rose 34.28% year-over-year to -$2.9 million; the TTM value through Dec 2025 reached -$12.1 million, up 51.07%, while the annual FY2025 figure was -$12.1 million, 51.07% up from the prior year.
  • Income towards Parent Company reached -$2.9 million in Q4 2025 per ICUCW's latest filing, up from -$3.5 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of -$2.0 million in Q2 2025 to a low of -$12.7 million in Q1 2024.
  • Average Income towards Parent Company over 3 years is -$5.3 million, with a median of -$4.1 million recorded in 2024.
  • Peak YoY movement for Income towards Parent Company: crashed 78.93% in 2024, then surged 70.29% in 2025.
  • A 3-year view of Income towards Parent Company shows it stood at -$9.5 million in 2023, then soared by 53.27% to -$4.4 million in 2024, then skyrocketed by 34.28% to -$2.9 million in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Income towards Parent Company are -$2.9 million (Q4 2025), -$3.5 million (Q3 2025), and -$2.0 million (Q2 2025).